
Last Updated February 26, 2026
Now Enrolling: Recurrent Cutaneous Squamous Cell Carcinoma (SCC) Study
We are currently enrolling adults with recurrent cutaneous squamous cell carcinoma (SCC) for an investigational treatment study. You may qualify if you:
- Are 18 years of age or older
- Have histologically confirmed recurrent cutaneous SCC
- Have previously failed first-line standard-of-care therapy
- Are able to undergo CT imaging


































